Multiple Assemblies exist for SMTL entry 6br3
Structure of RORgt in complex with a novel inverse agonist TAK-828.; X-RAY DIFFRACTION 3.00 Å

	SMTL ID 6br3.1 Ligands (4S)-2-METHYL-2,4-PENTANEDIOL; {cis-3-[(5R)-5-[(7-fluoro-1,1-dimethyl-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carbonyl]cyclobutyl}acetic acid Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer
	SMTL ID 6br3.2 Ligands (4S)-2-METHYL-2,4-PENTANEDIOL; {cis-3-[(5R)-5-[(7-fluoro-1,1-dimethyl-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carbonyl]cyclobutyl}acetic acid Polypeptides Nuclear receptor ROR-gamma Oligo-state homo-dimer
	SMTL ID 6br3.3 Ligands (4S)-2-METHYL-2,4-PENTANEDIOL; {cis-3-[(5R)-5-[(7-fluoro-1,1-dimethyl-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carbonyl]cyclobutyl}acetic acid Polypeptides Nuclear receptor ROR-gamma Oligo-state monomer